Non-dopamine Lesions in Parkinson's Disease

Glenda M. Halliday, PhD, is a neuroscientist currently working on the pathogenesis of neurodegenerative diseases. Her research has highlighted broader pathological involvement in Parkinson's disease and especially in dementia with Lewy bodies, with recent work suggesting that humoral immunity is involved. Roger A. Barker, PhD did his undergraduate training at the University of Oxford and then St Thomas Hospital in London. For the last 10 years he has been an honorary consultant in Neurology at the Addenbrooke's Hospital in Cambridge as well as being the University Reader in Clinical Neuroscience. He runs a large research group looking at the heterogeneity and natural history of PD as well as a basic science programme of work on the development of novel therapies for PD including stem cell based treatments. Dominic B. Rowe, FRACP, PhD, is Professor of Neurology at Macquarrie University in Sydney, Australia as well as a Consultant Neurologist at The University of Sydney. He first studied biochemistry and medicine and then completed training in internal medicine and neurology in Sydney before completing neurology training at Queen’s Square and Newcastle uponTyne. His doctoral studies on the pathogenesis of Parkinson’s disease were performed at Baylor College of Medicine, Texas and completed at the University of New South Wales. He has worked clinically as a neurologist and academic. His research is focused on the mechanisms involved in Parkinson’s disease and Motor Neurone Disease. He is the chairman of the Motor Neurone Disease Research Institute of Australia and is the author of three textbooks and more than 30 original articles.